AAAAAA

   
Results: 1-8 |
Results: 8
Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
Authors: Rudin, CM Holmlund, J Fleming, GF Mani, S Stadler, WM Schumm, P Monia, BP Johnston, JF Geary, R Yu, RZ Kwoh, TJ Dorr, FA Ratain, MJ
Citation: Cm. Rudin et al., Phase I trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer, CLIN CANC R, 7(5), 2001, pp. 1214-1220
Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice
Authors: Yu, RZ Zhang, H Geary, RS Graham, M Masarjian, L Lemonidis, K Crooke, R Dean, NM Levin, AA
Citation: Rz. Yu et al., Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice, J PHARM EXP, 296(2), 2001, pp. 388-395
Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkey
Authors: Yu, RZ Geary, RS Leeds, JM Watanabe, T Moore, M Fitchett, J Matson, J Burckin, T Templin, MV Levin, AA
Citation: Rz. Yu et al., Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha-ras mRNA in mouse and monkey, J PHARM SCI, 90(2), 2001, pp. 182-193
Studies on the initiation of a free-radical condensation hybrid polymerization system
Authors: Hong, XY Chen, QD Chen, M Yu, RZ Chen, J
Citation: Xy. Hong et al., Studies on the initiation of a free-radical condensation hybrid polymerization system, J APPL POLY, 79(7), 2001, pp. 1195-1200
Pharmacokinetic properties in animals
Authors: Geary, RS Yu, RZ Leeds, JM Watanabe, TA Henry, SP Levin, AA Templin, MV
Citation: Rs. Geary et al., Pharmacokinetic properties in animals, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 119-154
Pharmacokinetic properties in humans
Authors: Yu, RZ Geary, RS Watanabe, TA Levin, AA Schoenfeld, SL
Citation: Rz. Yu et al., Pharmacokinetic properties in humans, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, 2001, pp. 183-200
Measurment of soft X-ray spectrum by filter difference method
Authors: Sun, KX Jiang, SE Huang, TX Yi, RQ Cui, YL Wang, HB Chen, JS Yu, RZ Ding, YN Ding, YK Tang, DY Wen, SH
Citation: Kx. Sun et al., Measurment of soft X-ray spectrum by filter difference method, ACT PHY C E, 49(1), 2000, pp. 98-101
Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes
Authors: Yu, RZ Geary, RS Leeds, JM Watanabe, T Fitchett, JR Matson, JE Mehta, R Hardee, GR Templin, MV Huang, K Newman, MS Quinn, Y Uster, P Zhu, G Working, PK Horner, M Nelson, J Levin, AA
Citation: Rz. Yu et al., Pharmacokinetics and tissue disposition in monkeys of an antisense oligonucleotide inhibitor of Ha-ras encapsulated in stealth liposomes, PHARM RES, 16(8), 1999, pp. 1309-1315
Risultati: 1-8 |